Director/PDMR Shareholding

AI SummaryClose X

Fusion Antibodies plc has announced that its Non-Executive Chair, Simon Douglas, transferred 200,000 ordinary shares of 4 pence each to his daughters for nil consideration. Following this transfer, Mr. Douglas directly holds 861,062 ordinary shares, representing approximately 0.69 per cent. of the Company's issued share capital. This transaction, occurring outside a trading venue on 17 February 2026, is a notification of director dealing in accordance with market abuse regulations.

Disclaimer*

UK 100

Latest directors dealings